Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale, Piergiorgio Pettazzoni, Costas A. Lyssiotis, et al.
Nature (2014) Vol. 514, Iss. 7524, pp. 628-632
Open Access | Times Cited: 1110

Showing 1-25 of 1110 citing articles:

The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova, Craig B. Thompson
Cell Metabolism (2016) Vol. 23, Iss. 1, pp. 27-47
Open Access | Times Cited: 4781
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti, Jason W. Locasale
Trends in Biochemical Sciences (2016) Vol. 41, Iss. 3, pp. 211-218
Open Access | Times Cited: 3980
The biology and function of fibroblasts in cancer
Raghu Kalluri
Nature reviews. Cancer (2016) Vol. 16, Iss. 9, pp. 582-598
Closed Access | Times Cited: 3447
Fundamentals of cancer metabolism
Ralph J. DeBerardinis, Navdeep S. Chandel
Science Advances (2016) Vol. 2, Iss. 5
Open Access | Times Cited: 2518
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte, Sven Brandau, Shu‐Hsia Chen, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 2380
Cancer stem cells revisited
Eduard Batlle, Hans Clevers
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1124-1134
Open Access | Times Cited: 2349
Targeting autophagy in cancer
Jean M. Mulcahy Levy, Christina G. Towers, Andrew Thorburn
Nature reviews. Cancer (2017) Vol. 17, Iss. 9, pp. 528-542
Open Access | Times Cited: 2159
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden, Ralph J. DeBerardinis
Cell (2017) Vol. 168, Iss. 4, pp. 657-669
Open Access | Times Cited: 1908
Metabolic reprogramming and cancer progression
Brandon Faubert, Ashley Solmonson, Ralph J. DeBerardinis
Science (2020) Vol. 368, Iss. 6487
Open Access | Times Cited: 1720
Myeloid-derived suppressor cells coming of age
Filippo Veglia, Michela Perego, Dmitry I. Gabrilovich
Nature Immunology (2018) Vol. 19, Iss. 2, pp. 108-119
Open Access | Times Cited: 1543
Mitochondria and Cancer
Sejal Vyas, Elma Zaganjor, Marcia C. Haigis
Cell (2016) Vol. 166, Iss. 3, pp. 555-566
Open Access | Times Cited: 1426
Cancer metabolism: a therapeutic perspective
Ubaldo Martinez‐Outschoorn, Maria Peiris‐Pagès, Richard G. Pestell, et al.
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 1, pp. 11-31
Open Access | Times Cited: 1331
Metabolic pathways promoting cancer cell survival and growth
Lindsey K. Boroughs, Ralph J. DeBerardinis
Nature Cell Biology (2015) Vol. 17, Iss. 4, pp. 351-359
Open Access | Times Cited: 1296
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg, Navdeep S. Chandel
Nature Chemical Biology (2014) Vol. 11, Iss. 1, pp. 9-15
Open Access | Times Cited: 1239
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi, Federico Pietrocola, José Manuel Bravo‐San Pedro, et al.
The EMBO Journal (2015) Vol. 34, Iss. 7, pp. 856-880
Open Access | Times Cited: 1090
Mitochondrial metabolism and cancer
Paolo E. Porporato, Nicoletta Filigheddu, José Manuel Bravo‐San Pedro, et al.
Cell Research (2017) Vol. 28, Iss. 3, pp. 265-280
Open Access | Times Cited: 1059
Mitochondria and Cancer
Wei‐Xing Zong, Joshua D. Rabinowitz, Eileen White
Molecular Cell (2016) Vol. 61, Iss. 5, pp. 667-676
Open Access | Times Cited: 1051
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton, W. Gillies McKenna, Leoni A. Kunz‐Schughart, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 11, pp. 2482-2490
Open Access | Times Cited: 895
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie, Jessica K. Gagnon, Marc Therrien
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 10, pp. 607-632
Closed Access | Times Cited: 854
Targeting Metabolism for Cancer Therapy
Alba Luengo, Dan Y. Gui, Matthew G. Vander Heiden
Cell chemical biology (2017) Vol. 24, Iss. 9, pp. 1161-1180
Open Access | Times Cited: 829
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina, Yuting Sun, Marina Protopopova, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 1036-1046
Closed Access | Times Cited: 773
Drugging the 'undruggable' cancer targets
Chi V. Dang, E. Premkumar Reddy, Kevan M. Shokat, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 8, pp. 502-508
Open Access | Times Cited: 770
Metabolic Interactions in the Tumor Microenvironment
Costas A. Lyssiotis, Alec C. Kimmelman
Trends in Cell Biology (2017) Vol. 27, Iss. 11, pp. 863-875
Open Access | Times Cited: 751
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge, Estelle Saland, Fabienne de Toni, et al.
Cancer Discovery (2017) Vol. 7, Iss. 7, pp. 716-735
Open Access | Times Cited: 732
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids
Ling Huang, Audrey Holtzinger, Ishaan Jagan, et al.
Nature Medicine (2015) Vol. 21, Iss. 11, pp. 1364-1371
Open Access | Times Cited: 682
Page 1 - Next Page

Scroll to top